References
- Kozower BD, Sheng S, O'Brien SM, et al. STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thoracic Surg. 2010;90(3):875–881; discussion 881–873. https://doi.org/10.1016/j.athoracsur.2010.03.115 PMID:20732512
- Chi A, Liao Z, Nguyen NP, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol: J Eur Soc Therapeutic Radiology Oncol. 2010;94(1):1–11. https://doi.org/10.1016/j.radonc.2009.12.008 PMID:20074823
- Baumann P, Nyman J, Hoyer M, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol: J Eur Soc Therapeutic Radiology Oncol. 2008;88(3):359–367. https://doi.org/10.1016/j.radonc.2008.07.019 PMID:18768228
- Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol: Official J Eur Soc Med Oncol. 2013;24(6):1543–1548. https://doi.org/10.1093/annonc/mdt026 PMID:23425947
- Shah A, Hahn SM, Stetson RL, et al. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Cancer. 2013;119(17):3123–3132. https://doi.org/10.1002/cncr.28131 PMID:23720093
- Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 2013;119(15):2683–2691. https://doi.org/10.1002/cncr.28100 PMID:23605504
- Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101(7):1623–1631. https://doi.org/10.1002/cncr.20539 PMID:15378503
- Olsen JR, Robinson CG, El Naqa I, et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol, Biol, Phys. 2011;81(4):e299–303. https://doi.org/10.1016/j.ijrobp.2011.01.038 PMID:21477948
- Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https://doi.org/10.1186/1745-6215-8-16 PMID:17555582
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. https://doi.org/10.1002/sim.1186 PMID:12111919
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557 PMID:12958120
- Masatsugu H, Chen F, Matsuo Y, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thoracic Surg. 2015;99(4):1122–1129. https://doi.org/10.1016/j.athoracsur.2014.11.009 PMID:25661580
- Puri V, Crabtree TD, Kymes S, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thoracic Cardiovascular Surg. 2012;143(2):428–436. https://doi.org/10.1016/j.jtcvs.2011.10.078 PMID:22169443
- Robinson CG, DeWees TA, El Naqa IM, et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thoracic Oncol: Official Publ Int Assoc Study Lung Cancer. 2013;8(2):192–201. https://doi.org/10.1097/JTO.0b013e31827ce361 PMID:23287852
- Palma D, Visser O, Lagerwaard FJ, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother. Oncol: J Eur Soc Therapeutic Radiology Oncol. 2011;101(2):240–244. https://doi.org/10.1016/j.radonc.2011.06.029 PMID:21775007
- Kastelijn EA, El Sharouni SY, Hofman FN, et al. Clinical outcomes in early-stage NSCLC Treated with stereotactic body radiotherapy versus surgical resection. Anticancer Res. 2015;35(10):5607–5614 PMID:26408733
- Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis. Eur J Cancer. 2014;50(17):2932–2938. https://doi.org/10.1016/j.ejca.2014.09.006 PMID:25281527
- Port JL, Parashar B, Osakwe N, et al. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. Ann Thoracic Surg. 2014;98(4):1152–1159. https://doi.org/10.1016/j.athoracsur.2014.04.128 PMID:25085557
- Mokhles S, Nuyttens JJ, Maat AP, et al. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis. Ann Surgical Oncol. 2015;22(1):316–323. https://doi.org/10.1245/s10434-014-3860-x PMID:24962941
- Morgensztern D, Ng SH, Gao F, et al. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thoracic Oncol: Official Publ Int Assoc Study Lung Cancer. 2010;5(1):29–33. https://doi.org/10.1097/JTO.0b013e3181c5920c PMID:19952801
- Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol, Biol, Phys. 2012;84(5):1060–1070. https://doi.org/10.1016/j.ijrobp.2012.07.2354 PMID:22975611
- Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama. 2010;303(11):1070–1076. https://doi.org/10.1001/jama.2010.261 PMID:20233825
- Wang P, Zhang D, Guo XG, et al. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly. Medicine. 2016;95(52):e5723. https://doi.org/10.1097/MD.0000000000005723 PMID:28033277
- Parashar B, Singh P, Christos P, et al. Stereotactic body radiation therapy (SBRT) for early stage lung cancer delivers clinically significant radiation to the draining lymph nodes. J Radiosurgery SBRT 2013;2(4):339–340 PMID:24383044
- Varlotto JM, Recht A, Flickinger JC, et al. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer. 2009;115(5):1059–1069. https://doi.org/10.1002/cncr.24133 PMID:19152440
- Sun Z, Aubry MC, Deschamps C, et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thoracic Cardiovascular Surg. 2006;131(5):1014–1020. https://doi.org/10.1016/j.jtcvs.2005.12.057 PMID:16678584
- Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218–5227. https://doi.org/10.1002/cncr.24625 PMID:19672942
- Varlotto JM, Recht A, Flickinger JC, et al. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer. 2010;116(10):2390–2400. doi:10.1002/cncr.25047 PMID:20225332
- Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thoracic Surg. 2006;81(3):1013–1019; discussion 1019–1020. https://doi.org/10.1016/j.athoracsur.2005.06.066 PMID:16488712
- Stefani A, Nesci J, Casali C, et al. Wedge resection versus lobectomy for T1N0 non-small cell lung cancer. Minerva Chirurgica. 2012;67(6):489–498 PMID:23334112